The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis
The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal
The rise of e-pharmacies and tele-consultations during Covid-19 has made it easier for healthcare companies to access patient pools
Dr Reddy's would need to scale up manufacturing and obtain regulatory approval for marketing of this drug in respective countries, the company said
Political opposition from both the UK and the US could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak, Citigroup said
Firm says it has been in talks with at least eight buyers, including a few overseas companies, to supply the anti-retroviral drug
Revenues from operations for the quarter under review registered 16.4% growth at Rs 6158.43 crore as compared to Rs 5324.47 crore in the year ago period
Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes
The organisation today alleged that the NITI Aayog has added links to four e-pharmacy players
Domestic players will be free to price it; Dutch firm Mylan also to make the drug in India; no royalty for Gilead as yet
Ipca's Zerodol brand and its multiple variants used in treating pain and inflammation are an example of how this trend is playing out
The first day impact has been more on the pharma especially in the wake of 26 workers at Cadila Pharmaceuticals Ltd.'s facility in Ahmedabad testing positive for COVID-19
India has the potential to develop an antidote to Covid-19
The recovery seen in the markets from their March 2020 lows has been quite sharp, with the S&P BSE Sensex and the Nifty50 indices gaining 27.61 per cent and 27.18 per cent, respectively since then
The company has multiple growth engines given its focus on India/emerging markets and limited competition products in the US
They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused
Strides Pharma Science, Alkem Laboratories, Ajanta Pharma, Lupin, Ipca Laboratories, Jubilant Life Sciences and FDC were up in the range of 5 per cent to 10 per cent on the BSE
Uber, in a press release, had said that the partnership was aimed at ensuring that essential needs are fulfilled right in the safety of customers' homes
Indian airline operators and airports have been the first and the most adversely affected sector.
Combined capacity utilisation at all-India level is 60-70% - higher than in most other industries